​Virchow Laboratories Ltd. embarked its operations in 1981 in the field of API and since then has achieved major milestones. We are today the world''s largest producer of API Sulfamethoxazole and second largest producer of Ranitidine catering more than 90% and 60% worldwide requirement, respectively. 

After all these years, we are happy that we have not wavered from our dream. We can confidently state that we are well on the path of achieving objectives that we set out many years ago.
 

Since 2012 we ventured into domestic market with our presence pan India. having a well knit service oriented network of distributors and representatives. The presence was primarily in the niche of biologicals among the segments of esteemed medical practitioners and specialists in the feild of Orthopedicians, Gastroenterologists, Surgeons, Plastic Surgeons, Diabetic Surgeons and Consulting Physicians. The focus was in metros with direct servicing to patients, hospitals, institutions and nursing homes. We are happy to see many delighted doctors and patients who had laid their trust in our products.

The journey has been fulfilling, and with an excellent team at the helm we have also taken long strides to create a trusted presence internationally in over 20 countries across Asia, Africa, South-East Asia, Russia-CIS, and South America. We continuously strive to meet the strictest regulatory standards whilst offering an array of outstanding quality products at competitive pricing for affordable healthcare.

We hail from a strong ethical and responsible business family, the Virchow Group of Companies. Founded over 3 decades ago, the Virchow Group now has a global footprint in over 50 countries supporting about 3,500 employees with an annual turnover of over $600 million. The Virchow Group has a diversified business portfolio ranging from biologicals, pharmaceuticals, medical devices, and APIs.